Clinical Trials

Information about actively enrolling, ongoing, and completed clinical trials of cancer prevention, early detection, and supportive care, including phase I, II, and III agent and action trials and clinical trials management.

Clinical Trials Search

Search the DCP's clinical trials database for ongoing clinical trials in prevention, early detection, and the management of symptoms related to cancer and its treatments. 

Landmark Trials

Information on landmark clinical trials that evaluated cancer prevention interventions and cancer screening tests.

Clinical Trials Management

Information for researchers about developing, reporting, and managing NCI-funded cancer prevention clinical trials.
none

We chose to participate in a clinical trial to give our daughter the best chance of survival and to help find better treatment options for future kids diagnosed with neuroblastoma. ~ Makenna Lai's Mother

~Makenna Lai

Type(s) of Trial: Treatment

Trial Link(s): Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma

All Participants

Monograph on Engaging Older Adults in Clinical Trials

A JNCI monograph on Engaging Older Adults in Cancer Clinical Trials Conducted in the National Cancer Institute Clinical Trials Network. The articles, developed through working groups formed for an NCI workshop held in April 2021 to address this issue, provide recommendations and new and innovative solutions to common barriers to accrual.

Researchers Search the Genome for Clues to Early Age Onset Cancers in Racial/Ethnic Minorities

While researchers have identified some of the genetic changes that lead to cancer development, a key knowledge gap remains: finding the genetic changes that drive the development of cancers that arise at an earlier age than average (early onset) in racially and ethnically diverse populations.

New Onset Diabetes Cohort Sought to Unravel Complexities of Pancreatic Cancer Development

The National Cancer Institute is leading a project to create a cohort of people who are newly diagnosed with diabetes in the hopes that this group, who are at increased risk of developing pancreatic cancer, provide the clues in their blood and tissues to unravel some of the unknowns about this highly fatal cancer. The New Onset Diabetes Study (NOD) will include 10,000 people ages 50 to 85 across the United States.